Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Non-Current Assets: 2017-2025

Historic Non-Current Assets for Autolus Therapeutics (AUTL) over the last 6 years, with Sep 2025 value amounting to $147.4 million.

  • Autolus Therapeutics' Non-Current Assets rose 34.74% to $147.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $147.4 million, marking a year-over-year increase of 34.74%. This contributed to the annual value of $121.8 million for FY2024, which is 21.70% up from last year.
  • According to the latest figures from Q3 2025, Autolus Therapeutics' Non-Current Assets is $147.4 million, which was up 0.44% from $146.7 million recorded in Q2 2025.
  • In the past 5 years, Autolus Therapeutics' Non-Current Assets registered a high of $147.4 million during Q3 2025, and its lowest value of $2.5 million during Q3 2021.
  • In the last 3 years, Autolus Therapeutics' Non-Current Assets had a median value of $100.1 million in 2023 and averaged $109.8 million.
  • Data for Autolus Therapeutics' Non-Current Assets shows a peak YoY increase of 2,041.57% (in 2021) and a maximum YoY decrease of 97.15% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Autolus Therapeutics' Non-Current Assets stood at $65.0 million in 2021, then dropped by 0.69% to $64.5 million in 2022, then skyrocketed by 55.15% to $100.1 million in 2023, then rose by 21.70% to $121.8 million in 2024, then soared by 34.74% to $147.4 million in 2025.
  • Its Non-Current Assets was $147.4 million in Q3 2025, compared to $146.7 million in Q2 2025 and $130.6 million in Q1 2025.